Press Releases

Date Title and Summary Additional Formats
Toggle Summary Medidata Named Best Workplace in Technology by Great Place to Work® and FORTUNE
Employees value innovative technology initiatives and inclusive company culture Medidata is the only life science technology company on the list Company atmosphere and management transparency rank high on the list NEW YORK --(BUSINESS WIRE)--Jan. 18, 2019-- Great Place to Work and FORTUNE named
Toggle Summary Medidata Appoints Industry Leader Sastry Chilukuri as Executive Vice President of Digital and AI Solutions
NEW YORK --(BUSINESS WIRE)--Jan. 7, 2019-- Medidata  (NASDAQ:MDSO) today announced the addition of executive vice president of Digital and AI Solutions, Sastry Chilukuri to its senior leadership team. This press release features multimedia. View the full release here:
Toggle Summary Medidata to Present at the 37th Annual J.P. Morgan Healthcare Conference
NEW YORK --(BUSINESS WIRE)--Dec. 27, 2018-- Medidata (NASDAQ:MDSO) today announced that Tarek Sherif , chairman and chief executive officer, and Rouven Bergmann , chief financial officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan.
Toggle Summary Cala Health Streamlines Data and Operational Management for Neurological Device Study with Medidata Cloud
Study leverages Medidata Rave EDC, Edge eTMF and Edge Payments Cala Health unifies data and streamlines payments and document management on the Medidata Cloud Medidata supports observational study of first-in-class non-invasive, targeted nerve stimulator for the treatment of Essential Tremor The
Toggle Summary No Need for End of Study CDs: Medidata Introduces NEW Rave Digital EOS Media Delivery
Sponsors, CROs, and Sites Retain and Easily Access End Of Study Media Necessary to Meet Regulatory Requirements Reduces Regulatory Burden through Automatic Event Triggers from Rave EDC to Edge RCM Edge RCM Automates and Simplifies Access to EOS Documents Eliminates Need to Distribute and Use CDs
Toggle Summary Medidata Rave Omics Collaboration Uncovers Novel Insights for Rare Disease Research
Discovery of biomarker evidence in Castleman Disease exemplifies the value of personalized medicine in rare diseases The Castleman Disease Collaborative Network presented new research supported by Medidata at 60th Annual Meeting of the American Society of Hematology Application of Medidata Rave
Toggle Summary Medidata Rave Engage Wins Scrip Award for Best Sponsor-Focused Technological Development in Clinical Trials
Rave Engage Named Top Technology for Sponsors at 14th Annual Scrip Awards Medidata Wins Prestigious Industry Award for Third Consecutive Year Scrip Award Celebrates Innovation and Excellence in Biopharmaceutical Industry NEW YORK --(BUSINESS WIRE)--Nov.
Toggle Summary Federal Court Rejects Veeva’s Attack on Medidata’s Theft of Trade Secret Claims
NEW YORK --(BUSINESS WIRE)--Nov. 29, 2018-- The United States District Court for the Southern District of New York has rejected Veeva’s motion to dismiss Medidata’s complaint against Veeva for theft of trade secrets, the company announced today. “The Court’s decision allows us to continue with our
Toggle Summary Medidata to Present at Upcoming Investor Conferences
NEW YORK --(BUSINESS WIRE)--Nov. 21, 2018-- Medidata (NASDAQ:MDSO) today announced its participation in two upcoming investor conferences. Rouven Bergmann , chief financial officer, will present at the 30th Annual Piper Jaffray Healthcare Conference on Wednesday, Nov.
Toggle Summary Two Research Studies Supported by Medidata to be Presented at ASH 2018
Medidata Rave Omics Machine Learning Identifies New Evidence of Biomarkers in Rare Disease Research by the Castleman Disease Collaborative Network Memorial Sloan Kettering Cancer Center (MSK) Monitors Newly Diagnosed Myeloma Patients with Medidata ePRO NEW YORK --(BUSINESS WIRE)--Nov.

Investor Contact

Betsy Frank
+1 917 522 4620